PARP1 and cancer: Therefore, the down-regulation of FA/BRCA genes mediated by PAK1 creates a state of “FA/BRCAness”, and represents a rational approach for expanding the efficacy of PARP inhibitors to FA/BRCA-proficient cancer populations.